Juhani Knuuti
MD, professor, Turku PET Centre
jknuuti@utu.fi +358 29 450 2345 +358 50 059 2998 Kiinamyllynkatu 4-8 Turku |
Cardiovascular diseases, imaging
Juhani Knuuti’s research has focused on the physiology and pathophysiology, diagnosis and new therapies of coronary artery disease, heart failure and metabolic diseases. The research is also focused on developing and utilizing novel noninvasive imaging methods (PET, SPECT, echocardiography, MRI and CT) that will help to determine the risk and severity of CHD and heart failure and provide guidance for therapy decisions. The recent focus in cardiac research has been on vulnerable plaques, cardiac remodelling and multimodality and hybrid imaging. In metabolic and diabetes research, the focus has been in the interactions between different organs and heart in the pathogenesis and development of the cardiac diseases.
- Suomalaiset luottavat tieteeseen, mutta eivät kaikki (2022)
- Professoriblogi
- Targetting folate receptor-β expressing macrophages by 18F-labelled folate PET radiotracer in rat model of myocardial infarction (2022)
- European Journal of Nuclear Medicine and Molecular Imaging
- The Quantity of Epicardial Adipose Tissue in Patients Having Ablation for Atrial Fibrillation With and Without Heart Failure (2022)
- American Journal of Cardiology
- Tiedebarometri 2022: Suomi on edelleen luottamusyhteiskunta (2022)
- Turun Sanomat
- Time-resolved fluorescence based direct two-site apoA-I immunoassays and their clinical application in patients with suspected obstructive coronary artery disease (2022)
- Frontiers in Cardiovascular Medicine
- Tukea ukrainalaisille tieteentekijöille (2022)
- Professoriblogi
- Vessel and sex differences in pericoronary adipose tissue attenuation obtained with coronary CT in individuals without coronary atherosclerosis (2022)
- International Journal of Cardiovascular Imaging
- A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome (2021)
- Atherosclerosis
- Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging (2021)
- Journal of Nuclear Cardiology
- Assessment of myocardial viability with [15O]water PET: A validation study in experimental myocardial infarction (2021)
- Journal of Nuclear Cardiology



